Re-irradiation plus pembrolizumab: Phase II study for recurrent glioblastoma patients. Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, et al. Clin Cancer Res 2024 Nov 8. doi: 10.1158/1078-0432.CCR-24-1629.

Read + Share

Amedeo Smart

Independent Medical Education

Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, et al. Re-irradiation plus pembrolizumab: Phase II study for recurrent glioblastoma patients. Clin Cancer Res 2024 Nov 8. doi: 10.1158/1078-0432.CCR-24-1629.
PMID: 39513953